HQL
abrdn Life Sciences Investors
HQL
HQL
57 hedge funds and large institutions have $64.6M invested in abrdn Life Sciences Investors in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$599K | |
| 2 | +$509K | |
| 3 | +$397K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$344K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$291K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$1.13M | |
| 3 | -$632K | |
| 4 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$456K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$372K |